Mesa Laboratories Inc (MLAB)
Financial leverage ratio
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | — | 446,796 | 661,832 | 707,369 | 600,151 |
| Total stockholders’ equity | US$ in thousands | — | 145,393 | 393,480 | 393,801 | 406,227 |
| Financial leverage ratio | — | 3.07 | 1.68 | 1.80 | 1.48 |
March 31, 2025 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $—K ÷ $—K
= —
The financial leverage ratio for Mesa Laboratories Inc has shown fluctuations over the years. As of March 31, 2021, the ratio was 1.48, indicating a moderate level of leverage. Subsequently, the ratio increased to 1.80 by March 31, 2022, suggesting a slight increase in the company's reliance on debt.
In the following year, as of March 31, 2023, the ratio decreased to 1.68, indicating a decrease in leverage compared to the previous year. However, by March 31, 2024, the financial leverage ratio significantly rose to 3.07, signaling a substantial increase in the company's debt relative to its equity.
The data for March 31, 2025 is not provided, making it challenging to assess the company's current financial leverage ratio accurately. The significant increase in the ratio from 2023 to 2024 may indicate a shift in the company's capital structure towards higher debt levels. This trend could potentially pose higher financial risks for Mesa Laboratories Inc, such as increased interest payments and vulnerability to economic downturns. Keeping a close eye on the company's leverage and debt management strategies would be prudent for investors and stakeholders to ensure the sustainability of Mesa Laboratories Inc's financial health.
Peer comparison
Mar 31, 2025